| Dr Sheryl Praska, MD | |
|
18347 170th Street, Cresco, IA 52136-8323 | |
| (563) 547-4165 | |
| Not Available |
| Full Name | Dr Sheryl Praska |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 18347 170th Street, Cresco, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942261078 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5147-A (Wyoming) | Primary |
| Entity Name | Powell Valley Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699721316 PECOS PAC ID: 5092798561 Enrollment ID: O20040608000424 |
News Archive
The biotech drug maker was accused of paying kickbacks to increase sales of its anemia drug Aranesp.
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.
Roughly 780 million people around the world have no access to clean drinking water. According to the World Health Organization (WHO), 3.4 million people die from water-related diseases every year. ETH student Jeremy Nussbaumer set himself the goal of making a contribution to solving this problem.
Crescendo Bioscience announced today the commercial launch of Vectra DA, its first-in-class multi-biomarker blood test designed to aid physicians in managing patients with rheumatoid arthritis (RA). Vectra DA analyzes 12 key serum biomarkers to produce a single objective score that quantifies RA disease activity.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sheryl Praska, MD 18347 170th Street, Cresco, IA 52136-8323 Ph: () - | Dr Sheryl Praska, MD 18347 170th Street, Cresco, IA 52136-8323 Ph: (563) 547-4165 |
News Archive
The biotech drug maker was accused of paying kickbacks to increase sales of its anemia drug Aranesp.
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.
Roughly 780 million people around the world have no access to clean drinking water. According to the World Health Organization (WHO), 3.4 million people die from water-related diseases every year. ETH student Jeremy Nussbaumer set himself the goal of making a contribution to solving this problem.
Crescendo Bioscience announced today the commercial launch of Vectra DA, its first-in-class multi-biomarker blood test designed to aid physicians in managing patients with rheumatoid arthritis (RA). Vectra DA analyzes 12 key serum biomarkers to produce a single objective score that quantifies RA disease activity.
› Verified 4 days ago
Kimberlee Burckart, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 321 8th Ave W, Cresco, IA 52136 Phone: 563-547-2022 Fax: 563-547-3448 | |
Dr. Jon Dt Kammerer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 321 8th Ave W, Cresco, IA 52136 Phone: 563-547-2022 Fax: 563-547-3448 | |
Kelsey B'anca Thomas, Family Medicine Medicare: Medicare Enrolled Practice Location: 321 5th Ave W, Cresco, IA 52136 Phone: 563-547-2022 Fax: 563-547-3448 | |
David John Heine, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 235 8th Ave W, Cresco, IA 52136 Phone: 563-547-2101 Fax: 563-547-3448 | |
Dr. Paul J. Jensen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 321 8th Ave W, Cresco, IA 52136 Phone: 563-547-2022 |